117 related articles for article (PubMed ID: 21301779)
1. An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma.
Tuffal G; Roy S; Lavisse M; Brasseur D; Schofield J; Delesque Touchard N; Savi P; Bremond N; Rouchon MC; Hurbin F; Sultan E
Thromb Haemost; 2011 Apr; 105(4):696-705. PubMed ID: 21301779
[TBL] [Abstract][Full Text] [Related]
2. HPLC-MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples.
Karaźniewicz-Łada M; Danielak D; Teżyk A; Zaba C; Tuffal G; Główka F
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():105-12. PubMed ID: 23217313
[TBL] [Abstract][Full Text] [Related]
3. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
Liu C; Lu Y; Sun H; Yang J; Liu Y; Lai X; Gong Y; Liu X; Li Y; Zhang Y; Chen X; Zhong D
J Pharm Biomed Anal; 2018 Feb; 149():394-402. PubMed ID: 29154109
[TBL] [Abstract][Full Text] [Related]
5. P2y(12), a new platelet ADP receptor, target of clopidogrel.
Savi P; Labouret C; Delesque N; Guette F; Lupker J; Herbert JM
Biochem Biophys Res Commun; 2001 May; 283(2):379-83. PubMed ID: 11327712
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
[TBL] [Abstract][Full Text] [Related]
7. Development of a sensitive and fast UHPLC-MS/MS method for determination of clopidogrel, clopidogrel acid and clopidogrel active metabolite H4 in human plasma.
Hua W; Lesslie M; Hoffman BT; Binns C; Mulvana D
Bioanalysis; 2015; 7(12):1471-82. PubMed ID: 26168254
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS.
Takahashi M; Pang H; Kawabata K; Farid NA; Kurihara A
J Pharm Biomed Anal; 2008 Dec; 48(4):1219-24. PubMed ID: 18829199
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
[TBL] [Abstract][Full Text] [Related]
10. Identification and biological activity of the active metabolite of clopidogrel.
Savi P; Pereillo JM; Uzabiaga MF; Combalbert J; Picard C; Maffrand JP; Pascal M; Herbert JM
Thromb Haemost; 2000 Nov; 84(5):891-6. PubMed ID: 11127873
[TBL] [Abstract][Full Text] [Related]
11. Ultra-performance LC MS/MS method for quantification of clopidogrel active metabolite.
Delavenne X; Basset T; Zufferey P; Malouk N; Laporte S; Mismetti P
J Sep Sci; 2010 Jul; 33(13):1968-72. PubMed ID: 20533345
[TBL] [Abstract][Full Text] [Related]
12. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation.
Brandt JT; Payne CD; Wiviott SD; Weerakkody G; Farid NA; Small DS; Jakubowski JA; Naganuma H; Winters KJ
Am Heart J; 2007 Jan; 153(1):66.e9-16. PubMed ID: 17174640
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.
Karaźniewicz-Łada M; Danielak D; Burchardt P; Kruszyna L; Komosa A; Lesiak M; Główka F
Clin Pharmacokinet; 2014 Feb; 53(2):155-64. PubMed ID: 24127209
[TBL] [Abstract][Full Text] [Related]
15. Human Liver Cytochrome P450 Enzymes and Microsomal Thiol Methyltransferase Are Involved in the Stereoselective Formation and Methylation of the Pharmacologically Active Metabolite of Clopidogrel.
Liu C; Chen Z; Zhong K; Li L; Zhu W; Chen X; Zhong D
Drug Metab Dispos; 2015 Oct; 43(10):1632-41. PubMed ID: 26220948
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of P2Y₁₂ reduces physiological thromboxane levels.
Bhavaraju K; Georgakis A; Jin J; Gartner TK; Tomiyama Y; Nurden A; Nurden P; Kunapuli SP
Platelets; 2010; 21(8):604-9. PubMed ID: 21067313
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
[TBL] [Abstract][Full Text] [Related]
19. Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy.
Bal Dit Sollier C; Berge N; Boval B; Hovsepian L; Drouet L
Thromb Haemost; 2009 Jan; 101(1):116-22. PubMed ID: 19132197
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis.
van Giezen JJ; Berntsson P; Zachrisson H; Björkman JA
Thromb Res; 2009 Nov; 124(5):565-71. PubMed ID: 19692114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
